Register Below
To purchase your seat(s) for this webinar, complete the form below.
Fatal Five Plus and the Medications That Affect Them
- Live Webinar!
- Thursday, October 3, 2024
- 1:00 PM - 2:30 PM ET
- $30 with 1.5 Nursing CEs
- $20 without CEs
Email Webinars@ReplacingRisk.com to register 25 or more from the same organization and receive a 20% discount.
About the Webinar
Learn how to reduce the risk of morbidity and mortality in people with IDD.
Join Craig Escudé, MD, FAAFP, FAADM, and Nanette R. Wrobel, BS, RPh, for an updated discussion about the most common preventable causes of illness and death in people with IDD and the medications that can both positively and negatively affect them.
Topics include identification, prevention, and medication management of Bowel Obstruction, Aspiration, Dehydration, Seizures, and Sepsis, plus Gastroesophageal Reflux Disease (GERD).
Webinar Outcomes
Attendees will be able to:
- Describe six of the conditions most likely to lead to morbidity and mortality in people with IDD, known as the Fatal Five+, enabling them to identify and mitigate risks associated with these conditions.
- Describe the medications used to treat the Fatal Five+ conditions: Aspiration, Bowel Obstruction, Dehydration, Seizures, and Sepsis, plus Gastroesophageal Reflux Disease (GERD).
- Describe the medications that could exacerbate the Fatal Five+ conditions, enabling them to identify and mitigate risks associated with these medications.
About the Presenters
Nanette R. Wrobel, BS, RPh
Nanette is a pharmacist educator who for 40 years has done training, education and speaking for physicians, nurses and other health professionals. She focuses on clinical health and medication education in the area of intellectual and developmental disabilities. Medication management, drug safety, treatment assessments, new drugs on the market and disease states are some of the many topics she has discussed for organizations all over the country.
She is one of the clinical resources for a national pharmacy, Tarrytown Expocare, specializing in providing medications and medication management to facilities across the United States who care for individuals with I/DD.
Craig Escudé, MD, FAAFP, FAADM
Dr. Craig Escudé, MD is a Board certified Fellow of the American Academy of Family Physicians and the American Academy of Developmental Medicine. He is the author of “Clinical Pearls in IDD Healthcare” and “The Curriculum in IDD Healthcare”. Dr. Escude assumed the role as President of IntellectAbility in 2018.
IntellectAbility Webinar Registration Policies
- Please make sure your email addresses are correct! Once payment has been verified, a confirmation email will be sent to you with the webinar invitation details.
- To be eligible for CEs (if selected), the attendee must be logged in for at least 80% of the webinar and maintain the webinar in the foreground to confirm participation. After completion of the webinar, CE-eligible attendees will receive a link for an evaluation survey. Surveys must be completed by 12:00 pm EST on Friday, October 18, 2024. Your CE certificate will be sent via email 3-5 business days after the survey has been completed and attendance has been verified.
- Refunds & Cancellations: We do not offer refunds for no-shows. Registration can be cancelled any time prior to the webinar date. Cancelling your registration does not automatically trigger a refund. Please email Webinars@ReplacingRisk.com and we will process the refund.
- There are no registration refunds for any reason on or after the webinar date. If you need to cancel your registration before the webinar date, use the link in your Registration Confirmation email. Refunds are not automatic, as we do not receive notifications of registration cancellations. To request a refund or to ask questions, please email details to Webinars@replacingrisk.com.
